Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CCL5 |
| Upstream (Parents) |
|---|
| (<<) CD2 → CCL5 |
| (<<) TRBC1 → CCL5 |
| (<<) HCLS1 → CCL5 |
| (<<) TRAC → CCL5 |
| Downstream (Children) |
|---|
| CCL5 → TWF1 (>>) |
| CCL5 → TYMP (>>) |
| CCL5 → PRKCB (>>) |
| CCL5 → ZNF343 (>>) |
| CCL5 → GZMA (>>) |
| CCL5 → CD2 (>>) |
| CCL5 → RASGRP1 (>>) |
| CCL5 → CTSW (>>) |
| CCL5 → RPS11P1 (>>) |
| CCL5 → IL7R (>>) |
| CCL5 → CRTAM (>>) |
| CCL5 → CXCL10 (>>) |
| CCL5 → GNLY (>>) |
| CCL5 → TARP (>>) |
| CCL5 → CD3G (>>) |
| CCL5 → GZMH (>>) |
| CCL5 → PTPRCAP (>>) |
| CCL5 → TRAF3IP3 (>>) |
| CCL5 → IL16 (>>) |
| CCL5 → CD3E (>>) |
| CCL5 → AP1S1 (>>) |
